1. Home
  2. INDP vs SNTG Comparison

INDP vs SNTG Comparison

Compare INDP & SNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • SNTG
  • Stock Information
  • Founded
  • INDP 2000
  • SNTG 2009
  • Country
  • INDP United States
  • SNTG China
  • Employees
  • INDP N/A
  • SNTG N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • SNTG Finance: Consumer Services
  • Sector
  • INDP Health Care
  • SNTG Finance
  • Exchange
  • INDP Nasdaq
  • SNTG Nasdaq
  • Market Cap
  • INDP 5.0M
  • SNTG 4.8M
  • IPO Year
  • INDP N/A
  • SNTG 2021
  • Fundamental
  • Price
  • INDP $11.12
  • SNTG $1.84
  • Analyst Decision
  • INDP Strong Buy
  • SNTG
  • Analyst Count
  • INDP 2
  • SNTG 0
  • Target Price
  • INDP $8.50
  • SNTG N/A
  • AVG Volume (30 Days)
  • INDP 689.8K
  • SNTG 6.5K
  • Earning Date
  • INDP 08-11-2025
  • SNTG 07-07-2025
  • Dividend Yield
  • INDP N/A
  • SNTG N/A
  • EPS Growth
  • INDP N/A
  • SNTG N/A
  • EPS
  • INDP N/A
  • SNTG N/A
  • Revenue
  • INDP N/A
  • SNTG $107,507.00
  • Revenue This Year
  • INDP N/A
  • SNTG N/A
  • Revenue Next Year
  • INDP N/A
  • SNTG N/A
  • P/E Ratio
  • INDP N/A
  • SNTG N/A
  • Revenue Growth
  • INDP N/A
  • SNTG N/A
  • 52 Week Low
  • INDP $7.56
  • SNTG $1.43
  • 52 Week High
  • INDP $67.48
  • SNTG $3.97
  • Technical
  • Relative Strength Index (RSI)
  • INDP 98.13
  • SNTG 54.53
  • Support Level
  • INDP $0.31
  • SNTG $1.67
  • Resistance Level
  • INDP $0.71
  • SNTG $1.92
  • Average True Range (ATR)
  • INDP 0.07
  • SNTG 0.09
  • MACD
  • INDP 0.77
  • SNTG 0.01
  • Stochastic Oscillator
  • INDP 99.09
  • SNTG 62.96

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About SNTG Sentage Holdings Inc.

Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.

Share on Social Networks: